We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Modified Form of Curcumin is a Promising Alzheimer's Drug

News   Jan 10, 2018 | Original Story from the Salk Institute

 
Targeting Mitochondrial ATP Synthase to Treat Alzheimer's
 
 
 

RELATED ARTICLES

Eternal Sunshine of the Drug-less Mind

News

Forty to 60 percent of all people treated for substance use disorders relapse, presenting a major challenge to treatment success. New research shows that erasing memories that associate environmental cues with drug use significantly reduces drug seeking behaviors in rats, opening a potential avenue for developing more effective therapies to prevent relapse.

READ MORE

Making Resistant Melanomas Susceptible to Immunotherapy

News

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

READ MORE

Pre-symptomatic Skin Test for Prion Disease May Replace Brain Biopsy

News

Preclinical detection of prions has proven difficult, but new research suggests skin samples hold early signs of prion disease that precede neurologic symptoms.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE